Jul 30, 2026 06:30AM
May 7, 2026 06:30AM
Apr 30, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 12, 2026 07:30AM
Nov 6, 2025 07:30AM
Oct 30, 2025 07:30AM Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call
Aug 7, 2025 07:30AM
Aug 1, 2025 07:30AM
May 8, 2025 07:30AM
May 1, 2025 07:30AM
Mar 20, 2025 07:30AM
Mar 13, 2025 07:30AM
Nov 7, 2024 07:30AM Knight Therapeutics Reports Third Quarter 2024
Oct 31, 2024 07:30AM
Aug 8, 2024 07:30AM
Aug 1, 2024 07:30AM
May 9, 2024 07:30AM
May 2, 2024 07:30AM
Mar 21, 2024 07:30AM
Mar 14, 2024 07:30AM Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call
Nov 9, 2023 07:30AM
Nov 2, 2023 07:30AM
Aug 10, 2023 07:30AM
Aug 3, 2023 08:32PM
May 11, 2023 07:30AM
May 4, 2023 07:30AM
Mar 23, 2023 07:30AM Knight Therapeutics Reports Fourth Quarter and Year-End 2022 Results
Mar 16, 2023 07:30AM
Nov 10, 2022 07:30AM
Nov 3, 2022 07:30AM
Aug 11, 2022 07:30AM
Aug 4, 2022 07:30AM
May 12, 2022 07:30AM
May 5, 2022 07:30AM Notice of Knight Therapeutics' First Quarter 2022 Results Conference Call
Mar 24, 2022 07:30AM
Mar 17, 2022 07:30AM
Nov 11, 2021 07:30AM
Nov 4, 2021 07:30AM
Aug 13, 2021 07:30AM
Aug 6, 2021 07:30AM
Nov 13, 2020 07:30AM Knight Therapeutics Reports Third Quarter 2020 Results
Nov 6, 2020 07:30AM
Aug 13, 2020 07:30AM
Aug 6, 2020 07:30AM
Jun 26, 2020 07:30AM
Jun 18, 2020 06:30PM
May 29, 2020 05:01PM
Apr 30, 2020 05:01PM Knight Therapeutics Inc. Announces Extension of First Quarter 2020 Filings due to COVID-19
Mar 30, 2020 05:01PM

1,211,475 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All